Name | Title | Contact Details |
---|
MedPoint Communications, Inc is a Evanston, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Crozer-Keystone Health System is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Crozer-Keystone Health System is based in Chester, PA. You can find more information on Crozer-Keystone Health System at www.crozer.org
As a leading DSO, Heartland Dental provides supported dentists, hygienists, and non-clinical team members with world-class non-clinical administrative support to help them achieve sustainable professional and personal growth. What started from the entrepreneurial spirit of Rick Workman, DMD, with a single dental practice, has evolved into supporting over 2,700 dentists in over 1,700 dental offices across 38 states. Heartland Dental is not your typical Dental Support Organization. Its legacy of being built by a dentist, for dentists along with its doctor-led culture and business model enables supported doctors to be the leaders of their practice, working with their teams to focus on providing great dentistry while Heartland Dental focuses on providing support for the day-to-day non-clinical administrative workflow. You can discover more about Heartland Dental`s Doctor Difference by visiting www.heartland.com. Mission: To support doctors and their teams as they deliver the highest quality dental care and experiences to the communities they serve while providing exceptional careers and creating value for our stakeholders.
TRIMEDX is a technology-enabled, clinical asset management company, anchored on a strong foundation of clinical engineering, exclusively serving the healthcare community. As the largest independent technology-enabled clinical asset management company in the U.S., TRIMEDX provides strategic planning for - and management of - clinical assets to drive reductions in operational expenses, free up capital for new strategic initiatives, and deliver improved safety and cyber protection. Headquartered in Indianapolis, Indiana, TRIMEDX was built by providers, for providers, and leverages a history of expert clinical engineering to manage over $30 billion in clinical assets across thousands of locations. Our programs include flexible, yet comprehensive management of all patient-based technology, including biomedical, imaging, laboratory, and specialty equipment. Key features of our programs include: • Client Experience Center • Parts and Service Procurement Center • Regulatory Compliance Team • Computerized Maintenance Management System • Equipment Lifecycle Management In September of 2012, TRIMEDX was recognized by Modern Healthcare Magazine as the #1 Clinical Equipment Maintenance Contractor.
StemCells, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery primarily in the United States. Its lead therapeutic product candidate, HuCNS-SC cells (purified human neural stem cells), is in development as a potential treatment for a range of central nervous system disorders. The company has conducted a Phase I clinical trial in Pelizaeus-Merzbacher disease, a fatal myelination disorder in children. It is also conducting a Phase I/II clinical trial in chronic spinal cord injury; and has initiated a Phase I/II clinical trial in dry age-related macular degeneration, as well as is pursuing preclinical studies in Alzheimer’s disease. In addition, the company markets a rage of proprietary cell culture products, research grade human cells, and antibody reagents under the SC Proven brand. The proprietary cell culture products include iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff227, NDiff N2, and NDiff N27 supplements, as well as HEScGRO and ESGRO Complete; and antibody reagents comprise STEM24, STEM101, STEM121, and STEM123, which can be used for cell detection, isolation, and characterization. Further, StemCells is involved in developing and commercializing applications of its technologies to enable stem cell-based research. The company sells its tools and technologies products to researchers at academic institutions, pharmaceutical and biotechnology companies, and government laboratories. StemCells, Inc. was founded in 1988 and is headquartered in Newark, California.